Brain haemorrhage patients offered better treatment

May 29, 2013, Newcastle University

An international trial has provided surgeons with a formula which predicts when brain haemorrhage patients need surgery for the best outcome.

Brain haemorrhage affects some 4 million a year worldwide and the trial, run from Newcastle University, will help to ensure the best treatment is given at the right time.

David Mendelow, Professor of at Newcastle University and honorary consultant within the Newcastle Hospitals NHS Foundation Trust, who ran the trials, has devised a formula published today in The Lancet online which will allow surgeons to calculate when to intervene with surgery after an intracerebral haemorrhage. This occurs when the blood escapes from the into the brain itself to produce a solid clot.

Professor Mendelow said: "This study gives hope to patients at the time of their initial haemorrhagic stroke. Not only will some lives be saved, but we have shown that operating at the right time means that about one in five patients are able to regain their independence."

The results of the trial, known as STICH II (Surgical Trial in Lobar Intracerebral Haemorrhage) are published in The Lancet online and presented today at the European Stroke Conference in London. The , co-ordinated and completed at the Newcastle University Neurosurgery Unit involved 601 patients from 78 centres in 27 countries around the world.

Prior to this trial, surgeons did not have the detailed information telling them which patients benefited the most from surgery. Now this research provides surgeons with a formula which can be applied to fine tune decision-making for all these patients. It uses the established Glasgow Coma Score (GCS) – a neurological scale that aims to give a reliable, objective way of assessing and recording the of a person – the age of the patient and the volume of the clot. It provides surgeons with a prognosis-based outcome;

10 x GCS – Age (years) - 0.64 x Volume (ml)

The cut-point was established as 27.672 - meaning that any patient scoring less than this figure should be operated upon to offer them the best prognosis.

Professor Mendelow added: "Our work provides a definitive guide as to when surgery is needed and when it can avoided to ensure the best treatment for patients."

Explore further: New study should end debate over magnesium treatment for preventing poor outcome after haemorrhagic stroke

More information: Early surgery versus initial conservative treatment in patients with spontaneous supratentorial lobar intracerebral haematomas (STICH II): a randomised trial. Professor A David Mendelow, Dr Barbara A Gregson, Dr Elise N Rowan, Professor Gordon D Murray, Dr Anil Gholkar, Mr Patrick M Mitchell, STICH II Investigators. Lancet on-line 29th May 2013. www.thelancet.com/journals/lan … (13)60986-1/fulltext

Related Stories

New study should end debate over magnesium treatment for preventing poor outcome after haemorrhagic stroke

May 25, 2012
An international randomised trial and meta-analysis published Online First in The Lancet should put an end to the debate about the use of intravenous magnesium sulphate to prevent poor outcomes after haemorrhagic stroke. ...

Surgical procedure appears to improve outcomes after bleeding stroke

February 7, 2013
A minimally invasive procedure to remove blood clots in brain tissue after hemorrhagic stroke appears safe and may also reduce long-term disability, according to late-breaking research presented at the American Stroke Association's ...

Encouraging data from stem cell trial in stroke patients as plans for Phase II progress

May 27, 2013
Encouraging interim data from the world's first clinical trial examining the safety of neural stem cell treatment in stroke patients has been reported by researchers ahead of an application for Phase II trials.

Study shows promise, offers hope for brain hemorrhage patients

February 12, 2013
A new endoscopic surgical procedure has been shown to be safer and to result in better outcomes than the current standard medical treatment for patients who suffer strokes as a result of brain hemorrhages, UCLA neurosurgeons ...

Racial disparities in the surgical management of non-small cell lung cancer

May 21, 2013
The surgical management of non-small cell lung cancer (NSCLC) in U.S. hospitals varies widely depending on the race of the patient, according to a new study.

World's biggest stroke clot-buster trial reveals patient benefits

May 24, 2012
(Medical Xpress) -- Patients given a clot-busting drug within six hours of a stroke are more likely to make a better recovery than those who do not receive the treatment, new research has found.

Recommended for you

A nanoparticle inhalant for treating heart disease

January 18, 2018
A team of researchers from Italy and Germany has developed a nanoparticle inhalant for treating people suffering from heart disease. In their paper published in the journal Science Translational Medicine, the group describes ...

Starting periods before age of 12 linked to heightened risk of heart disease and stroke

January 15, 2018
Starting periods early—before the age of 12—is linked to a heightened risk of heart disease and stroke in later life, suggests an analysis of data from the UK Biobank study, published online in the journal Heart.

'Decorated' stem cells could offer targeted heart repair

January 10, 2018
Although cardiac stem cell therapy is a promising treatment for heart attack patients, directing the cells to the site of an injury - and getting them to stay there - remains challenging. In a new pilot study using an animal ...

Two simple tests could help to pinpoint cause of stroke

January 10, 2018
Detecting the cause of the deadliest form of stroke could be improved by a simple blood test added alongside a routine brain scan, research suggests.

Exercise is good for the heart, high blood pressure is bad—researchers find out why

January 10, 2018
When the heart is put under stress during exercise, it is considered healthy. Yet stress due to high blood pressure is bad for the heart. Why? And is this always the case? Researchers of the German Centre for Cardiovascular ...

Heart-muscle patches made with human cells improve heart attack recovery

January 10, 2018
Large, human cardiac-muscle patches created in the lab have been tested, for the first time, on large animals in a heart attack model. This clinically relevant approach showed that the patches significantly improved recovery ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.